SAN DIEGO -- For patients with traumatic bone fractures, there was no difference between oral aspirin and low-molecular-weight heparin (LMWH) injections as a bleeding prevention strategy, a ...

There was no difference between aspirin and apixaban for the endpoint of major bleeding, which included fatal bleeding, symptomatic bleeding in a critical area or organ, or bleeding causing a decrease ...

The researchers found that apixaban had similar rates of major bleeding and intracranial hemorrhage compared with aspirin (risk differences, 0.0 [95 percent confidence interval, −1.3 to 2.6] and ...

The researchers found that apixaban had similar rates of major bleeding and intracranial hemorrhage compared with aspirin (risk differences, 0.0 [95% CI, −1.3 to 2.6] and −0.2 [95% CI, −0.6 ...

Compared with aspirin, apixaban had similar rates of major bleeding (risk difference, 0 percentage points; 95% CI, –1.3 to 2.6) and intracranial hemorrhage (risk difference, –0.2 percentage ...

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin ...

Opinion Sonia Sotomayor Makes Misleading Comparison Between Gender Transitions for Children and ‘Taking Aspirin’ Isaac Schorr Dec 5th, 2024, 3:32 pm ...

The ARCADIA study was a multicenter, double-blind, randomized clinical trial conducted between 2017 and 2020.

No significant differences in efficacy or safety of 2 aspirin doses were found between male and female patients for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD).

For all but apixaban, the differences were statistically significant. Bleeding risk within 30 days was also numerically greater with these agents versus aspirin, with odds ratios of 1.28-1.43.